HIF1A and myocardial infarction: Similarly, the Danqi Pill reduced cardiac dysfunction and promoted cardiac glucose metabolism in postacute myocardial infarction HF rats by upregulating the expression of HIF-1α protein to activate the HIF-1 pathway [47].